An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules. uri icon

authors

  • Harper, Jane
  • Buchanan, Hazel
  • Le Provost, Gabrielle S
  • Donnellan, Zoe
  • Carreira, Ricardo J
  • Paston, Samantha J
  • Weigand, Luise U
  • Canestraro, Martina
  • Sanderson, Joseph P
  • Botta Gordon-Smith, Sophie
  • Lowe, Kate L
  • Adams, Katherine J
  • Rygiel, Karolina A
  • Powlesland, Alex S
  • Vuidepot, Annelise
  • Hassan, Namir J
  • Cameron, Brian J
  • Jakobsen, Bent K
  • Dukes, Joseph
  • Bossi, Giovanna
  • Wright, Debbie E
  • Stacey, Andrea R
  • Bedke, Nicole
  • Martinez-Hague, Ruth
  • Blat, Dan
  • Humbert, Laure

publication date

  • January 1, 2018